16th Dec 2008 13:43
RNS Number : 2241K
AGI Therapeutics plc
16 December 2008
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 15 December 2008 that Irish Life Investment Managers had increased its shareholding to 4,609,030 Ordinary Shares representing 6.84% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai